← Eichor
Condition: Melasma Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Melasma

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

The Use of Image-Based Computer Gradings in the Analysis of Acne, Rosacea, Melasma, and Seborrheic Dermatitis
NA · 1 location(s) · Integrative Skin Science and Research · NCT05942248
Development of Products Based on Secretom From Stem Cell Conditioned Medium for Melasma Therapy
NA · 2 location(s) · Dr.dr.Irma Bernadette, SpKK (K) · NCT06516419
Efficacy and Tolerability of the Tested Formula After 3 Months in Treatment of Facial Hyperpigmentation of 3 Origins
NA · 1 location(s) · Cosmetique Active International · NCT06268496
COMPARISON OF A COSMETIC SERUM AND 4% HYDROQUINONE FOR TREATING MELASMA OVER 84 DAYS
NA · 1 location(s) · Laboratoire Dermatologique ACM · NCT07071363
A Clinical Study to Evaluate the Efficacy in Improving Dark Spots After 8 Weeks of Use of Facial Sunscreens in Adult Par
NA · 1 location(s) · Kenvue Brands LLC · NCT07679945
Injectable Platelet-Rich Fibrin Versus Intradermal Tranexamic Acid for Melasma
NA · 1 location(s) · Kasr El Aini Hospital · NCT07540702
Ultrasound-Enhanced Delivery of Compound TXA Solution in Melasma
NA · 1 location(s) · The First Affiliated Hospital with Nanjing Medical Universit · NCT07202156
Oral Metformin for Treating Melasma in Latin American Women
Phase 1/Phase 2 · 1 location(s) · University of Puerto Rico · NCT06845540
Efficacy and Tolerability of Tested Formula After 3 Months of Treatment of Facial Hyperpigmentation of 3 Origins
NA · 1 location(s) · Cosmetique Active International · NCT06253468
Stem Cell Derived Exosomes in the Treatment of Melasma and Its Percutaneous Penetration
NA · 1 location(s) · Fujian Medical University Union Hospital · NCT06221787
Randomized Study Using SM-030 Gel for Adults With Melasma
Phase 2 · 2 location(s) · DermBiont, Inc. · NCT06454747
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.